These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
416 related items for PubMed ID: 22190000
1. Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat. Matikainen N, Taskinen MR, Stennabb S, Lundbom N, Hakkarainen A, Vaaralahti K, Raivio T. Eur J Endocrinol; 2012 Mar; 166(3):487-92. PubMed ID: 22190000 [Abstract] [Full Text] [Related]
2. Postprandial lipemia associates with liver fat content. Matikainen N, Mänttäri S, Westerbacka J, Vehkavaara S, Lundbom N, Yki-Järvinen H, Taskinen MR. J Clin Endocrinol Metab; 2007 Aug; 92(8):3052-9. PubMed ID: 17488790 [Abstract] [Full Text] [Related]
3. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease. Karpe F, Hellénius ML, Hamsten A. Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104 [Abstract] [Full Text] [Related]
4. Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism. Chan DC, Watts GF, Somaratne R, Wasserman SM, Scott R, Barrett PHR. Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1644-1655. PubMed ID: 29880491 [Abstract] [Full Text] [Related]
5. Relationship of postprandial fibroblast growth factor 21 with lipids, inflammation and metabolic dysfunction-associated fatty liver disease during oral fat tolerance test. Li X, Zheng K, Liu L, Zhang T, Gu W, Hou X, Geng J, Song G. Front Endocrinol (Lausanne); 2024 Jul; 15():1343853. PubMed ID: 38828414 [Abstract] [Full Text] [Related]
6. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Cassader M, Gambino R, Musso G, Depetris N, Mecca F, Cavallo-Perin P, Pacini G, Rizzetto M, Pagano G. Lipids; 2001 Oct; 36(10):1117-24. PubMed ID: 11768156 [Abstract] [Full Text] [Related]
7. Postprandial lipid and apolipoprotein responses following three consecutive meals associate with liver fat content in type 2 diabetes and the metabolic syndrome. Tushuizen ME, Pouwels PJ, Bontemps S, Rustemeijer C, Matikainen N, Heine RJ, Taskinen MR, Diamant M. Atherosclerosis; 2010 Jul; 211(1):308-14. PubMed ID: 20227695 [Abstract] [Full Text] [Related]
8. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes. Taskinen MR, Björnson E, Kahri J, Söderlund S, Matikainen N, Porthan K, Ainola M, Hakkarainen A, Lundbom N, Fermanelli V, Fuchs J, Thorsell A, Kronenberg F, Andersson L, Adiels M, Packard CJ, Borén J. Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392 [Abstract] [Full Text] [Related]
10. Effect of the fat composition of a single meal on the composition and cytotoxic potencies of lipolytically-releasable free fatty acids in postprandial plasma. Chung BH, Hennig B, Cho BH, Darnell BE. Atherosclerosis; 1998 Dec; 141(2):321-32. PubMed ID: 9862181 [Abstract] [Full Text] [Related]
11. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Mero N, Malmström R, Steiner G, Taskinen MR, Syvänne M. Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648 [Abstract] [Full Text] [Related]
12. The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men. Hamsten A, Silveira A, Boquist S, Tang R, Bond MG, de Faire U, Björkegren J. J Am Coll Cardiol; 2005 Apr 05; 45(7):1013-7. PubMed ID: 15808756 [Abstract] [Full Text] [Related]
13. Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia. Verseyden C, Meijssen S, Castro Cabezas M. J Lipid Res; 2002 Feb 05; 43(2):274-80. PubMed ID: 11861669 [Abstract] [Full Text] [Related]
14. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men. Matikainen N, Björnson E, Söderlund S, Borén C, Eliasson B, Pietiläinen KH, Bogl LH, Hakkarainen A, Lundbom N, Rivellese A, Riccardi G, Després JP, Alméras N, Holst JJ, Deacon CF, Borén J, Taskinen MR. PLoS One; 2016 Feb 05; 11(1):e0145890. PubMed ID: 26752550 [Abstract] [Full Text] [Related]
15. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma. Björkegren J, Karpe F, Milne RW, Hamsten A. J Lipid Res; 1998 Jul 05; 39(7):1412-20. PubMed ID: 9684744 [Abstract] [Full Text] [Related]
17. Early alterations in the postprandial VLDL1 apoB-100 and apoB-48 metabolism in men with strong heredity for type 2 diabetes. Johanson EH, Jansson PA, Gustafson B, Lönn L, Smith U, Taskinen MR, Axelsen M. J Intern Med; 2004 Feb 05; 255(2):273-9. PubMed ID: 14746565 [Abstract] [Full Text] [Related]